Every year, 72,680 people across the U.S. – or 199 people per day – receive a cancer diagnosis of the oral cavity, pharynx or ...

Head and neck cancers — including oral, throat, voice box (larynx), nasal cavity, sinuses, salivary glands, and thyroid cancers — represent a diverse group of diseases that are significantly ...

Efti stimulates both innate and adaptive immunity, enhancing the immune system's ability to target and destroy cancer cells. The FDA granted Efti fast track designation for first-line treatment of ...

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without ...

When they got back from their break ... Worryingly, doctors said they believed the growth on his neck had spread from the original cancer site, which they struggled to locate.